<article>
    <h2>Kodak has no plans to cease, go out of business, or file for bankruptcy</h2>
    <div>
<div>
<h3>Summary:</h3>
<p>Kodak has released a statement addressing what it considers to be misleading media reports concerning a loan agreement with the U.S. International Development Finance Corporation (DFC) from 2020. The statement aims to clarify the circumstances surrounding the loan and defend the company's actions and reputation. Kodak emphasizes that an internal review and an independent investigation found no wrongdoing by the company or its executives.</p>

<p>The intended loan was part of a plan to support Kodak's entry into the production of pharmaceutical ingredients, specifically those deemed essential for national security reasons, during the COVID-19 pandemic. The DFC had issued a Letter of Interest for a potential loan of $765 million under the Defense Production Act. This announcement led to a significant surge in Kodak's stock price.</p>

<p>However, concerns were raised regarding potential insider trading and the circumstances surrounding the loan announcement. This prompted internal and external investigations. Kodak maintains that it cooperated fully with all inquiries and that the investigations ultimately found no evidence of misconduct. The loan agreement was eventually put on hold and then terminated.</p>

<p>Kodak's statement asserts that despite the termination of the loan agreement, the company remains committed to exploring opportunities in the pharmaceutical sector and continuing its transformation. They believe in the potential of their existing infrastructure and expertise to contribute to the production of critical pharmaceutical ingredients. The statement concludes by reiterating Kodak's dedication to operating with integrity and transparency.</p>

<h3>Key Points:</h3>
<ul>
<li>Kodak addresses media reports it considers misleading regarding a potential loan from the DFC in 2020.</li>
<li>The loan was intended to support Kodak's entry into pharmaceutical ingredient production.</li>
<li>An internal review and an independent investigation found no wrongdoing by the company or its executives.</li>
<li>The loan agreement was ultimately put on hold and terminated.</li>
<li>Kodak remains committed to exploring opportunities in the pharmaceutical sector.</li>
<li>Kodak emphasizes its commitment to integrity and transparency.</li>
</ul>
</div>
</div>
</article>
